Somaxon Pharmaceuticals SOMX
-
Jazz Pharmaceuticals Can Hit An Interesting Note In 2012
By Jessica King Holden : Jazz Pharmaceuticals ( JAZZ ) caught a lot of buzz in 2011 amid a rumored buyout by Pfizer ( PFE ), which turned out to be a confirmation of a merger with Irish Pharmaceutical Azur Pharma. While news of a Pfizer buyout could have offered shareholders one of the sought after
-
UPDATE 1-Somaxon to explore strategic options, cut jobs
Dec 19 (Reuters) - Somaxon Pharmaceuticals Inc said it was exploring strategic alternatives, including a sale, and will cut jobs to conserve cash.
-
Somaxon Pharmaceuticals ( SOMX ) jumps in post-trade after saying it had a productive meeting with the FDA relating to the over-the-counter development program for its insomnia drug Silenor, developed ...
Somaxon Pharmaceuticals ( SOMX ) jumps in post-trade after saying it had a productive meeting ..... drug Silenor, developed jointly with Proctor & Gamble ( PG ). SOMX +22.5% AH. Post your comment!
-
What Happens After Intermezzo's Likely FDA Approval
Smith On Stocks submits: Transcept’s ( TSPT ) new drug for insomnia, Intermezzo, received a Complete Response Letter on October 26, 2009, in which the FDA acknowledged that it was effective. However, the agency failed to approve the drug because of concerns about dosing and potential next day ...
-
Somaxon Is a Sleeper in the Insomnia Market
Len Zehr submits: Somaxon Pharmaceuticalssomx (NASDAQ: SOMX ) is burning the midnight oil to get its message out about the safety and efficacy of Silenor, its recently launched drug to treat …
-
UPDATE 1-Somaxon sues Actavis over generic insomnia drug
May 10 (Reuters) - Somaxon Pharmaceuticals Inc said it filed a lawsuit against Icelandic generic drugmaker Actavis, challenging its application to make a copycat version of Somaxon's insomnia drug, Silenor.
-
Premarket gainers: [[VRTX]] +17%. [[OCLR]] +10%. [[CHS]] +5%. [[DTV]] +6%. [[CTIC]] +5%. [[SNV]] +4%. [[ SOMX ]] +4%.Losers: [[SATC]] -14%. [[HPQ]] -9%. [[CNXT]] -6%. [[GRMN]] -6%.
Premarket gainers: VRTX +17% . OCLR +10% . CHS +5% . DTV +6% . CTIC +5% . SNV +4% . SOMX +4% . Losers: SATC -14% . HPQ -9% . CNXT -6% . GRMN -6% . Post your comment!
-
UPDATE 1-Somaxon gets closer to insomnia drug patent
FEB 22 (Reuters) - Somaxon Pharmaceuticals Inc said the U.S. Patent and Trademark Office intends to issue a patent for the company's insomnia drug, Silenor, which has recently seen generic threat.
-
Premarket gainers: [[RHB]] +46%. [[KND]] +26%. [[CNXT]] +17%. [[XIDE]] +15%. [[ SOMX ]] +6%. [[CXZ]] +5%. [[CPST]] +5%. [[MT]] +5%. [[BYD]] +4%. [[MGM]] +4%. [[NTWK]] +4%. [[MOTR]] +4%. [[CCME]] ...
Premarket gainers: RHB +46% . KND +26% . CNXT +17% . XIDE +15% . SOMX +6% . CXZ +5% . CPST +5% . MT +5% . BYD +4% . MGM +4% . NTWK +4% . MOTR +4% . CCME +4% . Losers: BR -12 …
-
Somaxon Pharmaceuticals : Will FDA Approval Ever Pay Off?
Bert Wilkison submits: It has been nearly a year since Somaxon Pharmaceuticals ( SOMX ) received FDA approval for its lead product, Silenor, for the treatment of insomnia characterized by difficulty with sleep maintenance …